Form D · Other Health Care
XWELL, Inc.
New York, NY · CIK 0001410428
Offering snapshot reported Mar 3, 2026 · SEC filing
- Reported sold
- $31M Offering amount: $31M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2026 | Initial | $31,000,000 | No comparison | 1 | SEC filing |
| Jan 28, 2025 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
| Jul 23, 2019 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Dec 12, 2018 | Amendment | $2,000,000 | $0vs Nov 26, 2018 | 1 | SEC filing |
| Nov 26, 2018 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| May 24, 2018 | Initial | $4,438,000 | No comparison | 7 | SEC filing |
| Aug 18, 2016 | Initial | $1,733,826 | No comparison | 1 | SEC filing |
| Dec 19, 2011 | Amendment | $3,350,000 | $850,000vs Aug 4, 2011 | 11 | SEC filing |
| Aug 4, 2011 | Initial | $2,500,000 | No comparison | 8 | SEC filing |
| Jan 19, 2010 | Initial | $2,982,000 | No comparison | 35 | SEC filing |
| Feb 13, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.73M
- Finders' fees
- $0
- Form D file number
- 021-575171
Dominari Securities LLC also received warrants to purchase 5,333,277 shares of the Issuer's common stock, par value $0.01 per share.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Dominari Securities LLC | 000018975 |
Source: Form D, filed Mar 3, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Abbe | Director |
| Bruce Bernstein | Director |
| Thomas Ian Brown | Executive |
| Ellen Cohl | Executive |
| David Corre | Executive |
| John Engelman | Director |
| Ezra Ernst | Director, Executive |
| Salvatore Giardina | Director |
| Andrew Heyer | Director |
| Edward Jankowski | Director, Executive |
| Michael Lebowitz | Director |
| Jonathan Medved | Director, Executive, Promoter |
| Anastasia Nyrkovskaya | Executive |
| Andrew D. Perlman | Director, Executive |
| Douglas Satzman | Director, Executive |
| Edo Segal | Director |
| Philip Serlin | Director |
| Seth M. Siegel | Director |
| Ralph Simon | Director |
| Geoffrey M. Skolnik | Director |
| Donald Stout | Director |
| Robert Weinstein | Director |
| Gaelle Wizenberg | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
254 West 31 St Street 11 Th Floor
New York, NY, 10001
New York, NY, 10001